• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2006 Fiscal Year Final Research Report Summary

Roles of humoral and neural factors in angiogenesis and lymphangiogenesis in pathological conditions and their significance in molecular targeting therapy

Research Project

Project/Area Number 15390084
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field General pharmacology
Research InstitutionKITASATO UNIVERSITY

Principal Investigator

MAJIMA Masataka  Kitasato university, School of Medicine, Professor, 医学部, 教授 (70181641)

Co-Investigator(Kenkyū-buntansha) FUJITA Tomoe  Kitasato university, School of Medicine, Assistant Professor, 医学部, 講師 (20296510)
KAWAMURA Michiko  Kitasato university, School of Medicine, Research Associate, 医学部, 助手 (00154104)
HATANAKA Koh  Kitasato university, School of Medicine, Research Associate, 医学部, 助手 (00228470)
Project Period (FY) 2003 – 2006
Keywordsangiogenesis / lymphangiogenesis / cancer / chronic inflammation / prostaglandins / angiotensin / receptor signaling / neuropeptide
Research Abstract

Angiogenesis is also a critical step for development and metastasis of cancers. Proinflammatory mediators, such as PGs may have cell-autonomous effects on tumor cells in autocrine fashion, however, our results from tumor implantation models in knockout mice which lack the host receptor signaling clarified that host stromal signaling of a PGE_2 receptor, EP3 has a crucial role in tumor-associated angiogenesis through the induction of proaniogenic growth factors, and exhibited the landscaping effects on tumor cells. An EP3 antagonist inhibited tumor-associated angiogenesis in wild type mice, but not in EP3 knockout mice, suggesting that host EP3 receptor signaling is important in prevention of tumor-associated angiogenesis. Further, bone marrow transplantation experiment revealed that recruitment of bone marrow cells which express EP3 receptor is critical for angiogenesis in vivo. Relevant PGE2 is generated through the actions of COX-2 and an inducible PGE synthase, mPGES-1. Impressive p … More henotypes of mPGES-1 knockout mice implanted with tumor cells are reduced tumor growth and angiogenesis. Tumor-associated lymphangiogenesis was also suppressed with a COX-2 inhibitor. Thus, control of EP receptor signaling as well as recruitment of EP receptor expressing cells in the tumor microenvironment is likely to be a novel therapeutic approach against malignant solid tumors.
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by tissue-specific alternative splicing of the primary transcript of the calcitonin/CGRP gene. CGRP is widely distributed in the central and peripheral nervous systems and exhibits numerous biological activities in mammals. Tumor growth was significantly reduced in the sites of sensory nerve denervation. When a CGRP antagonist, CGRP8-37 was given, tumor growth was suppressed compared with vehicle infusion. In CGRP knockout mice, the tumor growth and tumor-associated angiogenesis were significantly reduced compared with wild type mice. In LLC bearing wild type mice, CGRP precursor mRNA levels in dorsal root ganglion were increased compared with non-treated mice. This increase was abolished by sensory nerve denervations. Further, we found that ulcer healing was significantly delayed in CGRP knockout mice with reductions in angiogenesis and VEGF expression. In co-culture system using HUVEC and fiboblasts, CGRP increased tube formation of endothelial cells. These results suggested that CGRP release from sensory nerves stimulated during tumor development and ulcer healing facilitates angiogenesis, and that CGRP may become a target of new treatment for cancers or gastrointestinal mucosal injury. Less

  • Research Products

    (13 results)

All 2006 2005 2004 2003

All Journal Article (12 results) Book (1 results)

  • [Journal Article] Intracellular Ca(2+) contributes to K(+)-induced increase in renal kallikrein secretion2006

    • Author(s)
      Fujita T, Qgino M, Daigo F, Yamaguchi T, Majima M
    • Journal Title

      Int Immunopharmacol 6(9)

      Pages: 1487-1495

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] A missing link between a high salt intake and blood pressure increase2006

    • Author(s)
      Katori M, Majima M
    • Journal Title

      J Pharmacol Sci 100(5)

      Pages: 370-390

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Intracellular Ca(2+) contributes to K(+)-induced increase in renal kallikrein secretion.2006

    • Author(s)
      Fujita T, Ogino M, Daigo F, Yamaguchi T, Majima M.
    • Journal Title

      Int Immunopharmacol. 6(9)

      Pages: 1487-1495

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] A missing link between a high salt intake and blood pressure increase.2006

    • Author(s)
      Katori M, Majima M.
    • Journal Title

      J Pharmacol Sci. 100(5)

      Pages: 370-390

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Comparison of maximum drug concentration and area under the time-concentration curve between humans and animals for oral and intravenous investigational drugs2005

    • Author(s)
      Fujita T, Matsumoto Y, Ozaki M, Majima M, Kumagai Y, Ohtani Y
    • Journal Title

      Carcinogenesis 26(2)

      Pages: 271-279

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Population pharmacokmetic-pharmacodynamic modeling of TF-505 using extension of indirect response model by incorporating a circadian rhythm in healthy volunteers2005

    • Author(s)
      Matsumoto Y, Fujita T, Ishida Y, Shimizu M, Kakuo H, Yamashita K, Majima M, Kumagai Y
    • Journal Title

      Biol Pharm Bull 28 (8)

      Pages: 1455-1461

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Comparison of maximum drug concentration and area under the time-concentration curve between humans and animals for oral and intravenous investigational drugs.2005

    • Author(s)
      Fujita T, Matsumoto Y, Ozaki M, Majima M, Kumagai Y, Ohtani Y.
    • Journal Title

      Carcinogenesis. 26(2)

      Pages: 271-279

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Population pharmacokinetic-pharmacodynamic modeling of TF-505 using extension of indirect response model by incorporating a circadian rhythm in healthy volunteers.2005

    • Author(s)
      Matsumoto Y, Fujita T, Ishida Y, Shimizu M, Kakuo H, Yamashita K, Majima M, Kumagai Y.
    • Journal Title

      Biol Pharm Bull. 28(8)

      Pages: 1455-1461

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.2004

    • Author(s)
      Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, ano H, Murama T, Arai H, Qida H, Yurugi-Kobayashi T, Yamashita JK, Katagiri H, ajima M, Yokode M, Kita T, Narumiya S
    • Journal Title

      J Clin Invest 114(6)

      Pages: 784-794

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.2004

    • Author(s)
      Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, Katagiri H, Majima M, Yokode M, Kita T, Narumiya S.
    • Journal Title

      J Clin Invest. 114(6)

      Pages: 784-794

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] The renal kallikrein-kinin system : its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension2003

    • Author(s)
      Katori M, Majima M
    • Journal Title

      Crit Rev Clin Lab Sci 40(1)

      Pages: 43-115

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] The renal kallikrein-kinin system : its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.2003

    • Author(s)
      Katori M, Majima M.
    • Journal Title

      Crit Rev Clin Lab Sci. 40(1)

      Pages: 43-115

    • Description
      「研究成果報告書概要(欧文)」より
  • [Book] 医科薬理学 第12章 抗炎症薬2005

    • Author(s)
      馬嶋 正隆 (分担)
    • Total Pages
      303-323
    • Publisher
      南山堂
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi